COVID-19 Impact on Global Osteogenesis Imperfecta Treatment Market Size, Status and Forecast 2020-2026

September 2020 | 91 pages | ID: C9654F0A59C9EN
QYResearch

Abstracts

This report focuses on the global Osteogenesis Imperfecta Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Osteogenesis Imperfecta Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Amgen Inc
• Bone Therapeutics SA
• Genzyme Corp
• Mereo Biopharma Group Plc

Market segment by Type, the product can be split into

• KAL-436
• BPS-804
• ALLOB
• Others

Market segment by Application, split into

• Hospital
• Clinic
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Osteogenesis Imperfecta Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Osteogenesis Imperfecta Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Osteogenesis Imperfecta Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Osteogenesis Imperfecta Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Osteogenesis Imperfecta Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 KAL-436
  1.4.3 BPS-804
  1.4.4 ALLOB
  1.4.5 Others
1.5 Market by Application
  1.5.1 Global Osteogenesis Imperfecta Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Clinic
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Osteogenesis Imperfecta Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Osteogenesis Imperfecta Treatment Industry
    1.6.1.1 Osteogenesis Imperfecta Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Osteogenesis Imperfecta Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Osteogenesis Imperfecta Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Osteogenesis Imperfecta Treatment Market Perspective (2015-2026)
2.2 Osteogenesis Imperfecta Treatment Growth Trends by Regions
  2.2.1 Osteogenesis Imperfecta Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Osteogenesis Imperfecta Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Osteogenesis Imperfecta Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Osteogenesis Imperfecta Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Osteogenesis Imperfecta Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Osteogenesis Imperfecta Treatment Players by Market Size
  3.1.1 Global Top Osteogenesis Imperfecta Treatment Players by Revenue (2015-2020)
  3.1.2 Global Osteogenesis Imperfecta Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Osteogenesis Imperfecta Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Osteogenesis Imperfecta Treatment Market Concentration Ratio
  3.2.1 Global Osteogenesis Imperfecta Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Osteogenesis Imperfecta Treatment Revenue in 2019
3.3 Osteogenesis Imperfecta Treatment Key Players Head office and Area Served
3.4 Key Players Osteogenesis Imperfecta Treatment Product Solution and Service
3.5 Date of Enter into Osteogenesis Imperfecta Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Osteogenesis Imperfecta Treatment Historic Market Size by Type (2015-2020)
4.2 Global Osteogenesis Imperfecta Treatment Forecasted Market Size by Type (2021-2026)

5 OSTEOGENESIS IMPERFECTA TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Osteogenesis Imperfecta Treatment Market Size by Application (2015-2020)
5.2 Global Osteogenesis Imperfecta Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Osteogenesis Imperfecta Treatment Market Size (2015-2020)
6.2 Osteogenesis Imperfecta Treatment Key Players in North America (2019-2020)
6.3 North America Osteogenesis Imperfecta Treatment Market Size by Type (2015-2020)
6.4 North America Osteogenesis Imperfecta Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Osteogenesis Imperfecta Treatment Market Size (2015-2020)
7.2 Osteogenesis Imperfecta Treatment Key Players in Europe (2019-2020)
7.3 Europe Osteogenesis Imperfecta Treatment Market Size by Type (2015-2020)
7.4 Europe Osteogenesis Imperfecta Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Osteogenesis Imperfecta Treatment Market Size (2015-2020)
8.2 Osteogenesis Imperfecta Treatment Key Players in China (2019-2020)
8.3 China Osteogenesis Imperfecta Treatment Market Size by Type (2015-2020)
8.4 China Osteogenesis Imperfecta Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Osteogenesis Imperfecta Treatment Market Size (2015-2020)
9.2 Osteogenesis Imperfecta Treatment Key Players in Japan (2019-2020)
9.3 Japan Osteogenesis Imperfecta Treatment Market Size by Type (2015-2020)
9.4 Japan Osteogenesis Imperfecta Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Osteogenesis Imperfecta Treatment Market Size (2015-2020)
10.2 Osteogenesis Imperfecta Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Osteogenesis Imperfecta Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Osteogenesis Imperfecta Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Osteogenesis Imperfecta Treatment Market Size (2015-2020)
11.2 Osteogenesis Imperfecta Treatment Key Players in India (2019-2020)
11.3 India Osteogenesis Imperfecta Treatment Market Size by Type (2015-2020)
11.4 India Osteogenesis Imperfecta Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Osteogenesis Imperfecta Treatment Market Size (2015-2020)
12.2 Osteogenesis Imperfecta Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Osteogenesis Imperfecta Treatment Market Size by Type (2015-2020)
12.4 Central & South America Osteogenesis Imperfecta Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Amgen Inc
  13.1.1 Amgen Inc Company Details
  13.1.2 Amgen Inc Business Overview and Its Total Revenue
  13.1.3 Amgen Inc Osteogenesis Imperfecta Treatment Introduction
  13.1.4 Amgen Inc Revenue in Osteogenesis Imperfecta Treatment Business (2015-2020))
  13.1.5 Amgen Inc Recent Development
13.2 Bone Therapeutics SA
  13.2.1 Bone Therapeutics SA Company Details
  13.2.2 Bone Therapeutics SA Business Overview and Its Total Revenue
  13.2.3 Bone Therapeutics SA Osteogenesis Imperfecta Treatment Introduction
  13.2.4 Bone Therapeutics SA Revenue in Osteogenesis Imperfecta Treatment Business (2015-2020)
  13.2.5 Bone Therapeutics SA Recent Development
13.3 Genzyme Corp
  13.3.1 Genzyme Corp Company Details
  13.3.2 Genzyme Corp Business Overview and Its Total Revenue
  13.3.3 Genzyme Corp Osteogenesis Imperfecta Treatment Introduction
  13.3.4 Genzyme Corp Revenue in Osteogenesis Imperfecta Treatment Business (2015-2020)
  13.3.5 Genzyme Corp Recent Development
13.4 Mereo Biopharma Group Plc
  13.4.1 Mereo Biopharma Group Plc Company Details
  13.4.2 Mereo Biopharma Group Plc Business Overview and Its Total Revenue
  13.4.3 Mereo Biopharma Group Plc Osteogenesis Imperfecta Treatment Introduction
  13.4.4 Mereo Biopharma Group Plc Revenue in Osteogenesis Imperfecta Treatment Business (2015-2020)
  13.4.5 Mereo Biopharma Group Plc Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Osteogenesis Imperfecta Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Osteogenesis Imperfecta Treatment Revenue
Table 3. Ranking of Global Top Osteogenesis Imperfecta Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Osteogenesis Imperfecta Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of KAL-436
Table 6. Key Players of BPS-804
Table 7. Key Players of ALLOB
Table 8. Key Players of Others
Table 9. COVID-19 Impact Global Market: (Four Osteogenesis Imperfecta Treatment Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Osteogenesis Imperfecta Treatment Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Osteogenesis Imperfecta Treatment Players to Combat Covid-19 Impact
Table 14. Global Osteogenesis Imperfecta Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Osteogenesis Imperfecta Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Osteogenesis Imperfecta Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Osteogenesis Imperfecta Treatment Market Share by Regions (2015-2020)
Table 18. Global Osteogenesis Imperfecta Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Osteogenesis Imperfecta Treatment Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Osteogenesis Imperfecta Treatment Market Growth Strategy
Table 24. Main Points Interviewed from Key Osteogenesis Imperfecta Treatment Players
Table 25. Global Osteogenesis Imperfecta Treatment Revenue by Players (2015-2020) (Million US$)
Table 26. Global Osteogenesis Imperfecta Treatment Market Share by Players (2015-2020)
Table 27. Global Top Osteogenesis Imperfecta Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Osteogenesis Imperfecta Treatment as of 2019)
Table 28. Global Osteogenesis Imperfecta Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Osteogenesis Imperfecta Treatment Product Solution and Service
Table 31. Date of Enter into Osteogenesis Imperfecta Treatment Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Osteogenesis Imperfecta Treatment Market Size by Type (2015-2020) (Million US$)
Table 34. Global Osteogenesis Imperfecta Treatment Market Size Share by Type (2015-2020)
Table 35. Global Osteogenesis Imperfecta Treatment Revenue Market Share by Type (2021-2026)
Table 36. Global Osteogenesis Imperfecta Treatment Market Size Share by Application (2015-2020)
Table 37. Global Osteogenesis Imperfecta Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. Global Osteogenesis Imperfecta Treatment Market Size Share by Application (2021-2026)
Table 39. North America Key Players Osteogenesis Imperfecta Treatment Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Osteogenesis Imperfecta Treatment Market Share (2019-2020)
Table 41. North America Osteogenesis Imperfecta Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. North America Osteogenesis Imperfecta Treatment Market Share by Type (2015-2020)
Table 43. North America Osteogenesis Imperfecta Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. North America Osteogenesis Imperfecta Treatment Market Share by Application (2015-2020)
Table 45. Europe Key Players Osteogenesis Imperfecta Treatment Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Osteogenesis Imperfecta Treatment Market Share (2019-2020)
Table 47. Europe Osteogenesis Imperfecta Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Osteogenesis Imperfecta Treatment Market Share by Type (2015-2020)
Table 49. Europe Osteogenesis Imperfecta Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Osteogenesis Imperfecta Treatment Market Share by Application (2015-2020)
Table 51. China Key Players Osteogenesis Imperfecta Treatment Revenue (2019-2020) (Million US$)
Table 52. China Key Players Osteogenesis Imperfecta Treatment Market Share (2019-2020)
Table 53. China Osteogenesis Imperfecta Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. China Osteogenesis Imperfecta Treatment Market Share by Type (2015-2020)
Table 55. China Osteogenesis Imperfecta Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. China Osteogenesis Imperfecta Treatment Market Share by Application (2015-2020)
Table 57. Japan Key Players Osteogenesis Imperfecta Treatment Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Osteogenesis Imperfecta Treatment Market Share (2019-2020)
Table 59. Japan Osteogenesis Imperfecta Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Osteogenesis Imperfecta Treatment Market Share by Type (2015-2020)
Table 61. Japan Osteogenesis Imperfecta Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Osteogenesis Imperfecta Treatment Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Osteogenesis Imperfecta Treatment Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Osteogenesis Imperfecta Treatment Market Share (2019-2020)
Table 65. Southeast Asia Osteogenesis Imperfecta Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Osteogenesis Imperfecta Treatment Market Share by Type (2015-2020)
Table 67. Southeast Asia Osteogenesis Imperfecta Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Osteogenesis Imperfecta Treatment Market Share by Application (2015-2020)
Table 69. India Key Players Osteogenesis Imperfecta Treatment Revenue (2019-2020) (Million US$)
Table 70. India Key Players Osteogenesis Imperfecta Treatment Market Share (2019-2020)
Table 71. India Osteogenesis Imperfecta Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. India Osteogenesis Imperfecta Treatment Market Share by Type (2015-2020)
Table 73. India Osteogenesis Imperfecta Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. India Osteogenesis Imperfecta Treatment Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Osteogenesis Imperfecta Treatment Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Osteogenesis Imperfecta Treatment Market Share (2019-2020)
Table 77. Central & South America Osteogenesis Imperfecta Treatment Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Osteogenesis Imperfecta Treatment Market Share by Type (2015-2020)
Table 79. Central & South America Osteogenesis Imperfecta Treatment Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Osteogenesis Imperfecta Treatment Market Share by Application (2015-2020)
Table 81. Amgen Inc Company Details
Table 82. Amgen Inc Business Overview
Table 83. Amgen Inc Product
Table 84. Amgen Inc Revenue in Osteogenesis Imperfecta Treatment Business (2015-2020) (Million US$)
Table 85. Amgen Inc Recent Development
Table 86. Bone Therapeutics SA Company Details
Table 87. Bone Therapeutics SA Business Overview
Table 88. Bone Therapeutics SA Product
Table 89. Bone Therapeutics SA Revenue in Osteogenesis Imperfecta Treatment Business (2015-2020) (Million US$)
Table 90. Bone Therapeutics SA Recent Development
Table 91. Genzyme Corp Company Details
Table 92. Genzyme Corp Business Overview
Table 93. Genzyme Corp Product
Table 94. Genzyme Corp Revenue in Osteogenesis Imperfecta Treatment Business (2015-2020) (Million US$)
Table 95. Genzyme Corp Recent Development
Table 96. Mereo Biopharma Group Plc Company Details
Table 97. Mereo Biopharma Group Plc Business Overview
Table 98. Mereo Biopharma Group Plc Product
Table 99. Mereo Biopharma Group Plc Revenue in Osteogenesis Imperfecta Treatment Business (2015-2020) (Million US$)
Table 100. Mereo Biopharma Group Plc Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Osteogenesis Imperfecta Treatment Market Share by Type: 2020 VS 2026
Figure 2. KAL-436 Features
Figure 3. BPS-804 Features
Figure 4. ALLOB Features
Figure 5. Others Features
Figure 6. Global Osteogenesis Imperfecta Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Osteogenesis Imperfecta Treatment Report Years Considered
Figure 11. Global Osteogenesis Imperfecta Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Osteogenesis Imperfecta Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Osteogenesis Imperfecta Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Osteogenesis Imperfecta Treatment Market Share by Players in 2019
Figure 16. Global Top Osteogenesis Imperfecta Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Osteogenesis Imperfecta Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Osteogenesis Imperfecta Treatment Revenue in 2019
Figure 18. North America Osteogenesis Imperfecta Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Osteogenesis Imperfecta Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Osteogenesis Imperfecta Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Osteogenesis Imperfecta Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Osteogenesis Imperfecta Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Osteogenesis Imperfecta Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Osteogenesis Imperfecta Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Amgen Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Amgen Inc Revenue Growth Rate in Osteogenesis Imperfecta Treatment Business (2015-2020)
Figure 27. Bone Therapeutics SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Bone Therapeutics SA Revenue Growth Rate in Osteogenesis Imperfecta Treatment Business (2015-2020)
Figure 29. Genzyme Corp Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Genzyme Corp Revenue Growth Rate in Osteogenesis Imperfecta Treatment Business (2015-2020)
Figure 31. Mereo Biopharma Group Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Mereo Biopharma Group Plc Revenue Growth Rate in Osteogenesis Imperfecta Treatment Business (2015-2020)
Figure 33. Bottom-up and Top-down Approaches for This Report
Figure 34. Data Triangulation
Figure 35. Key Executives Interviewed